Table 1.

Variation of biometric and physiological parameters in different treatment rats

Group	Body weight (g)		Ventral prostate weight (mg)	Seminal vesicles weight (mg)	Prostate index
	Initial	Final
Con	267.4 ± 15.6	451.4 ± 24.3	597.2 ± 94.8	1144.1 ± 165.0	1.3 ± 0.2
T	259.8 ± 17.2	383.6 ± 17.8***	1028.9 ± 94.6***	2524.0 ± 288.6	2.7 ± 0.2***
T + RSL3	266.1 ± 15.7	335.9 ± 23.4	572.1 ± 102.9	1337.0 ± 118.4	1.7 ± 0.3
T + TRO	263.3 ± 14.8	429.1 ± 23.1	711.9 ± 83.7	1282.9 ± 187.6	1.7 ± 0.3
T + RSL3 + TRO	264.4 ± 16.2	408.7 ± 21.5	539.3 ± 53.6 ns	1276.9 ± 164.8	1.3 ± 0.2

T testosterone; RSL3 RAS-selective lethal 3; TRO troglitazone

^***p < 0.001 Con vs. T

p < 0.01 T vs. T + RSL3; p < 0.001 T vs. T + RSL3

p < 0.01 T vs. T + TRO; p < 0.001 T vs. T + TRO;

p < 0.05 T + RSL3 vs. T + RSL3 + TRO; p < 0.001 T + RSL3 vs. T + RSL3 + TRO

ns p > 0.05 T + RSL3 vs. T + RSL3 + TRO